Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Impact of context-dependent autophagy states on tumor progression
Mohamad Assi, Alec C. Kimmelman
Nature Cancer (2023) Vol. 4, Iss. 5, pp. 596-607
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

Unveiling the mechanisms and challenges of cancer drug resistance
Sameer Ullah Khan, Kaneez Fatima, Shariqa Aisha, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 101
Lysosomes as coordinators of cellular catabolism, metabolic signalling and organ physiology
Carmine Settembre, Rushika M. Perera
Nature Reviews Molecular Cell Biology (2023) Vol. 25, Iss. 3, pp. 223-245
Closed Access | Times Cited: 88
Engineered hypoxia-responsive albumin nanoparticles mediating mitophagy regulation for cancer therapy
Wenyan Wang, Shunyu Yao, Jingjing Luo, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 3
PD-L1 induces autophagy and primary resistance to EGFR–TKIs in EGFR-mutant lung adenocarcinoma via the MAPK signaling pathway
Na Li, Ran Zuo, Yuchao He, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 8
Open Access | Times Cited: 9
New advances of natural products in non-small cell lung cancer: from mechanisms to therapies
Yuening Yang, Haolei Wang, Qianqian Xue, et al.
Journal of Ethnopharmacology (2025), pp. 119636-119636
Closed Access | Times Cited: 1
Lysosomes in Cancer—At the Crossroad of Good and Evil
Ida Eriksson, Karin Öllinger
Cells (2024) Vol. 13, Iss. 5, pp. 459-459
Open Access | Times Cited: 7
Targeting the TRIM14/USP14 Axis Enhances Immunotherapy Efficacy by Inducing Autophagic Degradation of PD-L1
Di Liu, Mengqiu Li, Zhiyao Zhao, et al.
Cancer Research (2024) Vol. 84, Iss. 17, pp. 2806-2819
Closed Access | Times Cited: 7
Autophagy in Disease Onset and Progression
Hao Wang, Xiushen Li, Qi Zhang, et al.
Aging and Disease (2023)
Open Access | Times Cited: 15
Enhancing the Antitumor Efficacy of Oncolytic Adenovirus Through Sonodynamic Therapy-Augmented Virus Replication
Junqiang Ding, Runping Su, 栄閣 楊, et al.
ACS Nano (2024) Vol. 18, Iss. 28, pp. 18282-18298
Closed Access | Times Cited: 4
ZDHHC7-mediated S -palmitoylation of ATG16L1 facilitates LC3 lipidation and autophagosome formation
Fujing Wei, Yu Wang, Jia Yao, et al.
Autophagy (2024) Vol. 20, Iss. 12, pp. 2719-2737
Closed Access | Times Cited: 4
USP1 promotes pancreatic cancer progression and autophagy by deubiquitinating ATG14
Leilei Li, Zhili Fan, Mengfei Liu, et al.
Journal of Biological Chemistry (2025), pp. 108190-108190
Open Access
DDX21 Controls Cell Cycle Progression and Autophagy in Pancreatic Cancer Cells
Adriana Leccese, Veronica Ruta, Valentina Panzeri, et al.
Cancers (2025) Vol. 17, Iss. 4, pp. 570-570
Open Access
Co-inhibition of RAGE and TLR4 sensitizes pancreatic cancer to irreversible electroporation in mice by disrupting autophagy
Cuifang Ye, Jiangping Wu, Linrong Li, et al.
Acta Pharmacologica Sinica (2025)
Closed Access
PD-L1-Targeting Autophagy Modulator to Upregulate MHC-I and Activate Photo-Immunotherapy for Metastatic Tumor Eradication
Zhen‐Ming Lu, Ziwen Qiu, Yanmei Li, et al.
ACS Applied Materials & Interfaces (2025)
Closed Access
ATP6AP1 promotes cell proliferation and tamoxifen resistance in luminal breast cancer by inducing autophagy
Zhengwei Yan, Aidi Huang, Dongwen Ma, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access
Inflammasomes and autophagy in cancer: unlocking targeted therapies
Jitendra Gupta, Mohammed H. Mohammed, Tawfeeq Alghazali, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
SLC34A2 promotes cell proliferation by activating STX17‐mediated autophagy in esophageal squamous cell carcinoma
Yi Xu, Shiyu Duan, Wen Ye, et al.
Thoracic Cancer (2024) Vol. 15, Iss. 17, pp. 1369-1384
Open Access | Times Cited: 3
NXPH4 mediated by m5C contributes to the malignant characteristics of colorectal cancer via inhibiting HIF1A degradation
Lei Yang, Jiawen Shi, Mingyang Zhong, et al.
Cellular & Molecular Biology Letters (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 3
In vivo CRISPR knockout screen identifies p47 as a suppressor of HER2+ breast cancer metastasis by regulating NEMO trafficking and autophagy flux
Mingang Hao, Peixin Lu, Sarah Sotropa, et al.
Cell Reports (2024) Vol. 43, Iss. 2, pp. 113780-113780
Open Access | Times Cited: 3
Iron oxide nanoparticles induce ferroptosis via the autophagic pathway by synergistic bundling with paclitaxel
Qi Nie, Wenqing Chen, Tianmei Zhang, et al.
Molecular Medicine Reports (2023) Vol. 28, Iss. 4
Open Access | Times Cited: 7
JD‐02, a novel Hsp90 inhibitor, induces ROS/SRC axis‐dependent cytoprotective autophagy in colorectal cancer cells
Lan Ni, Yuan Su, Qiongzhen Zeng, et al.
Molecular Carcinogenesis (2024) Vol. 63, Iss. 6, pp. 1038-1050
Closed Access | Times Cited: 2
Advantages and disadvantages of mitochondrial mechanism (mitophagy) for cancer treatment
Amir Herić, Amar Silajdžić, Tarik Zubčević
World Journal of Biology Pharmacy and Health Sciences (2024) Vol. 18, Iss. 2, pp. 064-072
Open Access | Times Cited: 1
Unveiling the Promise: Navigating Clinical Trials 1978–2024 for PDAC
A. Domínguez, M Perz, Yi Xu, et al.
Cancers (2024) Vol. 16, Iss. 21, pp. 3564-3564
Open Access | Times Cited: 1
Exploiting autophagy balance in T and NK cells as a new strategy to implement adoptive cell therapies
Manuela Giansanti, Tobias Theinert, Sarah Katharina Boeing, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 3
Metabolomics combined with mathematical analysis reveals metabolic pathways specific to metastatic cancers
Shinya Sato, Toshinari Yamashita
Translational Breast Cancer Research (2024) Vol. 5, pp. 15-15
Open Access
Page 1 - Next Page

Scroll to top